United Services Automobile Association Karyopharm Therapeutics Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$5.66 - $11.85 $616,283 - $1.29 Million	-108,884 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$4.32 - $6.43 $4,039 - $6,012	935 Added 0.87%	108,884 $652,000
Q4 2018 Feb 13, 2019	SELL	$8.2 - $16.95 $44,279 - $91,530	-5,400 Reduced 4.76%	107,949 $1.01 Million
Q2 2018 Sep 27, 2018	BUY	$12.0 - $19.88 $1.09 Million - $1.81 Million	91,116 Added 409.82%	113,349 $1.93 Million
Q2 2018 Aug 10, 2018	SELL	$12.0 - $19.88 $769,716 - $1.28 Million	-64,143 Reduced 74.26%	22,233 $1.17 Million
Q1 2018 May 14, 2018	BUY	$9.92 - $17.25 $46,683 - $81,178	4,706 Added 5.76%	86,376 $1.16 Million
Q4 2017 Feb 14, 2018	BUY	$9.15 - $11.99 $23,927 - $31,353	2,615 Added 3.31%	81,670 $784,000
Q3 2017 Nov 14, 2017	BUY	$8.15 - $11.16 $644,298 - $882,253	79,055	79,055 $868,000

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.